Metformin induces suppression of NAD(P)H oxidase activity in podocytes. 2010

Agnieszka Piwkowska, and Dorota Rogacka, and Maciej Jankowski, and Marek Henryk Dominiczak, and Jan Kazimierz Stepiński, and Stefan Angielski
Mossakowski Medical Research Centre Polish Academy of Sciences, Gdańsk, Poland. apiwkowska@cmdik.pan.pl

Hyperglycemia increases the production of reactive oxygen species (ROS). NAD(P)H oxidase, producing superoxide anion, is the main source of ROS in diabetic podocytes and their production contributes to the development of diabetic nephropathy. We have investigated the effect of an antidiabetic drug, metformin on the production of superoxide anion in cultured podocytes and attempted to elucidate underlying mechanisms. The experiments were performed in normal (NG, 5.6mM) and high (HG, 30mM) glucose concentration. Overall ROS production was measured by fluorescence of a DCF probe. Activity of NAD(P)H oxidase was measured by chemiluminescence method. The AMP-dependent kinase (AMPK) activity was determined by immunobloting, measuring the ratio of phosphorylated AMPK to total AMPK. Glucose accumulation was measured using 2-deoxy-[1,2-(3)H]-glucose. ROS production increased by about 27% (187+/-8 vs. 238+/-9 arbitrary units AU, P<0.01) in HG. Metformin (2mM, 2h) markedly reduced ROS production by 45% in NG and 60% in HG. Metformin decreased NAD(P)H oxidase activity in NG (36%) and HG (86%). AMPK activity was increased by metformin in NG and HG (from 0.58+/-0.07 to. 0.99+/-0.06, and from 0.53+/-0.03 to 0.64+/-0.03; P<0.05). The effects of metformin on the activities of NAD(P)H oxidase and AMPK were abolished in the presence of AMPK inhibitor, compound C. We have shown that metformin decreases production of ROS through reduction of NAD(P)H oxidase activity. We also have demonstrated relationship between activity of NAD(P)H oxidase and AMPK.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008687 Metformin A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) Dimethylguanylguanidine,Dimethylbiguanidine,Glucophage,Metformin HCl,Metformin Hydrochloride,HCl, Metformin,Hydrochloride, Metformin
D011494 Protein Kinases A family of enzymes that catalyze the conversion of ATP and a protein to ADP and a phosphoprotein. Protein Kinase,Kinase, Protein,Kinases, Protein
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006943 Hyperglycemia Abnormally high BLOOD GLUCOSE level. Postprandial Hyperglycemia,Hyperglycemia, Postprandial,Hyperglycemias,Hyperglycemias, Postprandial,Postprandial Hyperglycemias
D000091162 AMP-Activated Protein Kinase Kinases Protein Serine-threonine kinases that phosphorylate the 63-kDa subunit of AMP-ACTIVATED PROTEIN KINASES. This action results in reactivation of AMP-ACTIVATED PROTEIN KINASE activity and downstream signaling aimed at decreased metabolism. AMP-PK Reactivator,AMP-PK Reactivators,AMPK Kinase,AMP Activated Protein Kinase Kinases,AMP PK Reactivator,AMP PK Reactivators
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D013481 Superoxides Highly reactive compounds produced when oxygen is reduced by a single electron. In biological systems, they may be generated during the normal catalytic function of a number of enzymes and during the oxidation of hemoglobin to METHEMOGLOBIN. In living organisms, SUPEROXIDE DISMUTASE protects the cell from the deleterious effects of superoxides. Superoxide Radical,Superoxide,Superoxide Anion

Related Publications

Agnieszka Piwkowska, and Dorota Rogacka, and Maciej Jankowski, and Marek Henryk Dominiczak, and Jan Kazimierz Stepiński, and Stefan Angielski
March 1998, Kidney international,
Agnieszka Piwkowska, and Dorota Rogacka, and Maciej Jankowski, and Marek Henryk Dominiczak, and Jan Kazimierz Stepiński, and Stefan Angielski
March 2000, Biochemical and biophysical research communications,
Agnieszka Piwkowska, and Dorota Rogacka, and Maciej Jankowski, and Marek Henryk Dominiczak, and Jan Kazimierz Stepiński, and Stefan Angielski
March 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society,
Agnieszka Piwkowska, and Dorota Rogacka, and Maciej Jankowski, and Marek Henryk Dominiczak, and Jan Kazimierz Stepiński, and Stefan Angielski
September 2002, Circulation research,
Agnieszka Piwkowska, and Dorota Rogacka, and Maciej Jankowski, and Marek Henryk Dominiczak, and Jan Kazimierz Stepiński, and Stefan Angielski
June 2007, American journal of physiology. Renal physiology,
Agnieszka Piwkowska, and Dorota Rogacka, and Maciej Jankowski, and Marek Henryk Dominiczak, and Jan Kazimierz Stepiński, and Stefan Angielski
January 1991, Nihon Sanka Fujinka Gakkai zasshi,
Agnieszka Piwkowska, and Dorota Rogacka, and Maciej Jankowski, and Marek Henryk Dominiczak, and Jan Kazimierz Stepiński, and Stefan Angielski
February 2009, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Agnieszka Piwkowska, and Dorota Rogacka, and Maciej Jankowski, and Marek Henryk Dominiczak, and Jan Kazimierz Stepiński, and Stefan Angielski
January 1977, Biochimica et biophysica acta,
Agnieszka Piwkowska, and Dorota Rogacka, and Maciej Jankowski, and Marek Henryk Dominiczak, and Jan Kazimierz Stepiński, and Stefan Angielski
May 2007, Journal of immunology (Baltimore, Md. : 1950),
Agnieszka Piwkowska, and Dorota Rogacka, and Maciej Jankowski, and Marek Henryk Dominiczak, and Jan Kazimierz Stepiński, and Stefan Angielski
July 2009, Antioxidants & redox signaling,
Copied contents to your clipboard!